On the other hand, Akt signaling can be activated by upregulation of fibronectin on stroma cells and contributes to platinum resistance in ovarian cancer cells [119], and high levels of FN1 in serum have positive correlation with recurrence and shorter progression free survival in ovarian cancer patients under platinum-based therapy [120]. The gene discussed is AKT1; the disease is ovarian carcinoma.